Literature DB >> 10395041

Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C.

G S Baroni1, A Pastorelli, A Manzin, A Benedetti, L Marucci, L Solforosi, A Di Sario, E Brunelli, F Orlandi, M Clementi, G Macarri.   

Abstract

BACKGROUND/AIMS: The involvement of a direct viral cytopathic effect or an immune-mediated mechanism in the progression of hepatic damage in chronic hepatitis C is controversial. The type of immune response is itself a matter of controversy, and histological data are lacking. The aim of this study was to identify the factors associated with the progression of liver injury in 30 HCV/RNA-positive untreated patients with chronic hepatitis.
METHODS: Necroinflammatory and architectural damage were evaluated using Ishak's score. Activated hepatic stellate cells (HSC) were visualized by immunohistochemistry for alpha-smooth muscle actin (alphaSMA) and quantitated by morphometry. Plasma HCV/RNA was evaluated using a competitive RT-PCR method. To study the type of immune response involved in the progression of liver injury, interferon gamma (IFNgamma)-positive cells (as expression of a Th1-like response) were evaluated by immunohistochemistry and quantitated by morphometry.
RESULTS: HSC were mostly detected close to areas of lobular necroinflammation or lining fibrotic septa. The alphaSMA- and Sirius Red-positive parenchyma correlated significantly with necroinflammatory and architectural scores. IFNgamma-positive cells were detected in periportal areas associated with the inflammatory infiltrates and significantly correlated with architectural damage. No relationship was found between the histological features of liver injury and viral load.
CONCLUSIONS: HSC activation and progression of liver injury are unrelated to viral load but associated with a Th1-like response, a plausible target for the treatment of chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395041     DOI: 10.1111/j.1478-3231.1999.tb00038.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  18 in total

Review 1.  Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered.

Authors:  Valeer J Desmet
Journal:  Virchows Arch       Date:  2011-02-02       Impact factor: 4.064

2.  Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients.

Authors:  Nadia Bouzgarrou; Elham Hassen; Olfa Bahri; Sallouha Gabbouj; Nabil Ben Mami; Henda Triki; Lotfi Chouchane
Journal:  Hepatol Int       Date:  2011-02-08       Impact factor: 6.047

Review 3.  Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer.

Authors:  D R McGivern; S M Lemon
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

4.  Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis.

Authors:  Veysel Tahan; Fatih Eren; Erol Avsar; Dilek Yavuz; Meral Yuksel; Ebru Emekli; Nese Imeryuz; Cigdem Celikel; Hafize Uzun; Goncagul Haklar; Nurdan Tozun
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

Review 5.  Stellate cell contraction: role, regulation, and potential therapeutic target.

Authors:  Russell K Soon; Hal F Yee
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

Review 6.  Host genetic factors and antiviral immune responses to hepatitis C virus.

Authors:  Chloe L Thio
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

7.  Effects of PPARg agonist pioglitazone on rat hepatic fibrosis.

Authors:  Guang-Jin Yuan; Ming-Liang Zhang; Zuo-Jiong Gong
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

8.  Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C.

Authors:  T Asselah; N Boyer; M-C Guimont; D Cazals-Hatem; F Tubach; K Nahon; H Daïkha; D Vidaud; M Martinot; M Vidaud; C Degott; D Valla; P Marcellin
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

9.  Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses.

Authors:  Fumihiro Ohara; Aisuke Nii; Yojiro Sakiyama; Megumi Tsuchiya; Shinji Ogawa
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

Review 10.  Fibrosis progression in chronic hepatitis C virus infection.

Authors:  G W McCaughan; J George
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.